The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 338:1923-1924 June 25, 1998 Number 26
NextNext

Treatment of Paraphilia with an Analogue of Gonadotropin-Releasing Hormone

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Rösler, A.
To the Editor: The article by Rösler and Witztum (Feb. 12 issue)1 reporting the beneficial effects of the inhibition of gonadotropin secretion in men with paraphilia is an important contribution, but several problems will have to be solved before this therapy can be used widely in sexual offenders. They include the difficulty of identifying sexual offenders whom it would be "safe" to treat and give parole status; the potential legal liability for the manufacturer of the drug, the institutional sponsor, and the participating physicians and other staff members in case any of the men committed a criminal act while enrolled . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.